美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

全球合伙

49.81

+0.89991.84%

成交量：1.18万

成交额：59.00万

市值：16.77亿

市盈率：20.67

高：51.08

开：49.27

低：48.92

收：48.91

数据加载中...

总览公司新闻公告

Global Partners(GLP.US)：2024年Q4财报实现营收41.86亿美元，前值为44.09亿美元，预期值为58亿美元；每股收益为0.52美元，前值为1.41美元，预期值为0.24美元。

Global Partners2024年第四季度GAAP每股收益$0.52超预期$0.24，销售额$41.9亿低于预期$58亿

多款双靶点GLP-1激动剂研发迎来新进展，减肥适应症热度不减

【众生药业：控股子公司获得一类创新药RAY1225注射液III期临床试验伦理批件】金融界2月27日消息，近日，众生药业控股子公司众生睿创自主研发的一类创新多肽药物RAY1225注射液在超重/肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验获得组长单位北京大学人民医院和共同组长单位中山大学孙逸仙纪念医院伦理审查批件，批准项目开展。RAY1225注射液是具有全球自主知识产权的创新结构多肽药物，属于长效GLP-1类药物，具有双重激动活性，可调节人体代谢和控制血糖。本次III期临床试验组长单位伦理批件的获得，标志着该试验将全面启动。该注射液获得伦理批件对公司短期财务状况和经营业绩不构成重大影响，但临床试验存在风险和不确定性，公司将按规定履行信息披露义务。

【众生药业：RAY1225注射液III期临床试验伦理批件获批】众生药业公告，控股子公司众生睿创自主研发的RAY1225注射液在超重/肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验(REBUILDING-2)获得组长单位北京大学人民医院和共同组长单位中山大学孙逸仙纪念医院伦理审查批件，批准项目开展。RAY1225注射液是众生睿创研发的、具有全球自主知识产权的创新结构多肽药物，属于长效GLP-1类药物，具有GLP-1受体和GIP受体双重激动活性，可通过刺激胰岛素分泌、延缓胃排空等机制调节人体代谢和控制血糖，有望用于降糖、减肥、代谢综合征等多种代谢性疾病的治疗。

野村升翰森制药目标价2%至18.36港元维持中性评级

通化东宝(600867.SH)：GLP-1/GIP双靶点受体激动剂获得降糖适应症Ib期临床试验总结报告

华东医药：GLP-1/GIP双靶点长效激动剂HDM1005注射液新适应症中国IND获得批准

华泰证券：全球GLP-1产品空缺较大，并购潮有望持续

华泰证券：全球GLP-1产品空缺较大，并购潮有望持续

GLP-1研发风云录：MetaBio折戟沉沙，辉瑞缘何错失良机？

【华东医药：HDM1005注射液临床试验申请获批】华东医药公告，2025年2月24日，全资子公司杭州中美华东制药有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，由中美华东申报的HDM1005注射液临床试验申请获得批准。HDM1005注射液用于阻塞性睡眠呼吸暂停（OSA）合并肥胖或超重成人患者的治疗，是多肽类人GLP-1受体和GIP受体的双靶点长效激动剂。该药物在中国的临床试验于2024年3月获得批准，适应症为2型糖尿病、超重或肥胖人群的体重管理。目前，HDM1005注射液正在积极推进II期临床试验相关工作。

华泰证券：国产GLP-1产品有望抢占全球市场份额

中信建投：出海迎来新机会，持续看好创新药行业

【中信建投：出海迎来新机会，持续看好创新药行业】中信建投研报表示，近年来，创新药企营业收入逐步增长，亏损实现缩窄，研发费用基本持平。在政策上，集采与医保谈判常态化，商保带来潜在增量，对创新药的支持力度有望进一步增加。在技术上，全球ADC药物2023年销售额达104亿美元，中国相关公司加速ADC布局与推进，逐渐迎来收获期；GLP-1减重赛道发展成熟，竞争从单一减重升级到多重获益，新靶点存在潜在出海机会；IO多抗赛道AK112率先实现突破，TCE技术从血液瘤走向实体瘤和自免。我国创新药全球竞争力持续增强，NewCo模式成为创新药出海新选择。国家政策鼓励创新药发展，新技术推动行业快速发展，出海迎来新机会，我们持续看好创新药行业。

金十数据整理：每日港股市场要闻速递（2月20日周四）

服用GLP-1降糖药后失明？诺和诺德回应：不能证实存在因果关系

每日经济新闻

歌礼制药-B(01672)宣布小分子口服GLP-1R激动剂ASC30美国Ib期多剂量递增研究前两个队列取得积极期中结果

Websea启动全球合伙人招募计划，携手共建加密生态新未来

Websea启动全球合伙人招募计划，携手共建加密生态新未来

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/GLP/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GLP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","market":"US","secType":"STK","nameCN":"全球合伙","latestPrice":49.8099,"timestamp":1745350449955,"preClose":48.91,"halted":0,"volume":11792,"delay":0,"floatShares":25096277,"shares":33668256,"eps":2.41,"marketStatus":"交易中","change":0.8999,"latestTime":"04-22 15:35:51 EDT","open":49.27,"high":51.08,"low":48.915,"amount":589957.53344,"amplitude":0.044265,"askPrice":50.7,"askSize":250,"bidPrice":48.95,"bidSize":100,"shortable":3,"etf":0,"ttmEps":2.41,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1127966400000,"exchange":"NYSE","adjPreClose":48.91,"postHourTrading":{"tag":"盘后","latestPrice":48.91,"preClose":48.91,"latestTime":"19:06 EDT","volume":30,"amount":1463.275,"timestamp":1745276819507},"volumeRatio":0.404988,"impliedVol":0.4708,"impliedVolPercentile":0.644},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLP\",,,,,undefined,":{"symbol":"GLP","floatShares":25096277,"roa":"4.19%","roe":"14.20%","lyrEps":2.44604,"volumeRatio":0.404988,"shares":33668256,"dividePrice":2.96,"high":51.08,"amplitude":0.044265,"preClose":48.91,"low":48.915,"week52Low":37.0034,"pbRate":"2.62","psRate":"0.10","week52High":60,"institutionHeld":0.407,"latestPrice":49.8099,"committee":-0.428571,"eps":2.41,"divideRate":0.059426,"volume":11792,"delay":0,"ttmEps":2.41,"open":49.27,"prevYearClose":46.55,"prevWeekClose":50.77,"prevMonthClose":53.38,"prevQuarterClose":53.38,"fiveDayClose":49.13,"twentyDayClose":52.68,"sixtyDayClose":51.42},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLP\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514321856","title":"Global Partners(GLP.US)：2024年Q4财报实现营收41.86亿美元，前值为44.09亿美元，预期值为58亿美元；每股收益为0.52美元，前值为1.41美元，预期值为0.24美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321856","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321856?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 21:12","pubTimestamp":1740748333,"startTime":"0","endTime":"0","summary":"Global Partners(GLP.US)：2024年Q4财报实现营收41.86亿美元，前值为44.09亿美元，预期值为58亿美元；每股收益为0.52美元，前值为1.41美元，预期值为0.24美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28211248466390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GLP"],"gpt_icon":0},{"id":"1142688838","title":"Global Partners2024年第四季度GAAP每股收益$0.52超预期$0.24，销售额$41.9亿低于预期$58亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1142688838","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142688838?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 21:04","pubTimestamp":1740747881,"startTime":"0","endTime":"0","summary":"Global Partners报告显示，其季度每股收益为$0.52，超过分析师一致预期的$0.24，上涨了116.67%。公司季度销售额为$41.9亿，低于分析师一致预期的$58亿，相差27.86%。此外，与去年同期销售额$44.1亿相比下降了5.06%。以上内容来自Benzinga Earnings专栏，原文如下：Global Partners  reported quarterly earnings of $0.52 per share which beat the analyst consensus estimate of $0.24 by 116.67 percent. This is a 63.12 percent decrease over earnings of $1.41 per share from the same period last year.  The company reported quarterly sales of $4.19 billion which missed the analyst consensus estimate of $5.80 b","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Global Partners2024年第四季度GAAP每股收益$0.52超预期$0.24，销售额$41.9亿低于预期$58亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP"],"gpt_icon":0},{"id":"2514362428","title":"多款双靶点GLP-1激动剂研发迎来新进展，减肥适应症热度不减","url":"https://stock-news.laohu8.com/highlight/detail?id=2514362428","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514362428?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 10:40","pubTimestamp":1740710437,"startTime":"0","endTime":"0","summary":"2月26日，国家药监局药品审评中心（CDE）官网披露，诺和诺德的1类新药amycretin注射液获批临床试验，拟用于降低超重或肥胖成人患者的体重。该药为长效GLP-1和胰淀素受体激动剂。今年以来，包括华东医药等在内的多家企业研发的双靶点GLP-1激动剂在减重适应症上迎来研发新进展，受到资本市场关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502283332829665.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502283332829665.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4590","GLP","BK4144"],"gpt_icon":0},{"id":"2514798938","title":"【众生药业：控股子公司获得一类创新药RAY1225注射液III期临床试验伦理批件】金融界2月27日消息，近日，众生药业控股子公司众生睿创自主研发的一类创新多肽药物RAY1225注射液在超重/肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验获得组长单位北京大学人民医院和共同组长单位中山大学孙逸仙纪念医院伦理审查批件，批准项目开展。RAY1225注射液是具有全球自主知识产权的创新结构多肽药物，属于长效GLP-1类药物，具有双重激动活性，可调节人体代谢和控制血糖。本次III期临床试验组长单位伦理批件的获得，标志着该试验将全面启动。该注射液获得伦理批件对公司短期财务状况和经营业绩不构成重大影响，但临床试验存在风险和不确定性，公司将按规定履行信息披露义务。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514798938","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514798938?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 17:56","pubTimestamp":1740650165,"startTime":"0","endTime":"0","summary":"金融界2月27日消息，近日，众生药业控股子公司众生睿创自主研发的一类创新多肽药物RAY1225注射液在超重/肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验获得组长单位北京大学人民医院和共同组长单位中山大学孙逸仙纪念医院伦理审查批件，批准项目开展。本次III期临床试验组长单位伦理批件的获得，标志着该试验将全面启动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27175648431102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4590","BK0077","BK0188","03347","002317","BK1583","BK1576","BK4144","06978","BK1574","BK0239","BK1141","GLP","BK1161","BK4134","III","159992"],"gpt_icon":0},{"id":"2514879859","title":"【众生药业：RAY1225注射液III期临床试验伦理批件获批】众生药业公告，控股子公司众生睿创自主研发的RAY1225注射液在超重/肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验(REBUILDING-2)获得组长单位北京大学人民医院和共同组长单位中山大学孙逸仙纪念医院伦理审查批件，批准项目开展。RAY1225注射液是众生睿创研发的、具有全球自主知识产权的创新结构多肽药物，属于长效GLP-1类药物，具有GLP-1受体和GIP受体双重激动活性，可通过刺激胰岛素分泌、延缓胃排空等机制调节人体代谢和控制血糖，有望用于降糖、减肥、代谢综合征等多种代谢性疾病的治疗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514879859","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514879859?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 17:55","pubTimestamp":1740650130,"startTime":"0","endTime":"0","summary":"众生药业公告，控股子公司众生睿创自主研发的RAY1225注射液在超重/肥胖参与者的安全性和有效性的多中心、随机、双盲、安慰剂对照的III期临床试验(REBUILDING-2)获得组长单位北京大学人民医院和共同组长单位中山大学孙逸仙纪念医院伦理审查批件，批准项目开展。RAY1225注射液是众生睿创研发的、具有全球自主知识产权的创新结构多肽药物，属于长效GLP-1类药物，具有GLP-1受体和GIP受体双重激动活性，可通过刺激胰岛素分泌、延缓胃排空等机制调节人体代谢和控制血糖，有望用于降糖、减肥、代谢综合征等多种代谢性疾病的治疗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27175548431160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK1576","BK0077","BK0188","GLP","III","BK1583","BK4590","BK0239","BK4134","002317","BK4144","03347"],"gpt_icon":0},{"id":"2514733890","title":"野村升翰森制药目标价2%至18.36港元 维持中性评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2514733890","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514733890?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 10:36","pubTimestamp":1740537390,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1589","BK4590","03692","MSD","BK1191","BK4144","BK1583","GLP"],"gpt_icon":0},{"id":"2514549320","title":"通化东宝(600867.SH)：GLP-1/GIP双靶点受体激动剂获得降糖适应症Ib期临床试验总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2514549320","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514549320?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 16:09","pubTimestamp":1740470979,"startTime":"0","endTime":"0","summary":"格隆汇2月25日丨通化东宝公布，全资子公司东宝紫星（杭州）生物医药有限公司完成了一项关键Ib期临床试验并获得临床试验总结报告，研究结果显示达到主要终点目标。公司在获得注射用THDBH120药物临床试验批准后，根据国内化学药品创新药相关指导原则，近日完成了一项“在中国成人2型糖尿病患者中评价注射用THDBH120多次给药的安全性、耐受性、药代动力学和药效动力学的随机、双盲、安慰剂对照的Ib期临床研究”，研究结果达到了主要终点目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/25160948369004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4144","BK4590","BK1576","BK1141","BK0196","BK0239","BK1583","GLP","03347","BK0188","600867"],"gpt_icon":0},{"id":"2514813230","title":"华东医药：GLP-1/GIP双靶点长效激动剂HDM1005注射液新适应症中国IND获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2514813230","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514813230?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 09:37","pubTimestamp":1740447447,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0196","GLP","BK1191","BK0209","LU1969619763.USD","03347","BK1574","LU2328871848.SGD","01477","BK4144","BK1583","BK0183","BK0187","000963","BK1576","BK0188","BK4590","BK1141","BK0175","BK0132"],"gpt_icon":0},{"id":"2514008324","title":"华泰证券：全球GLP-1产品空缺较大，并购潮有望持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2514008324","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514008324?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 08:18","pubTimestamp":1740442738,"startTime":"0","endTime":"0","summary":"华泰证券认为，GLP-1已展现较大的市场潜力，而目前海外MNC仅诺和诺德和礼来两巨头销售领先，但尚未形成完整产品矩阵，其他MNC产品仍处于临床阶段，竞争格局尚未定型，产品空缺较大。而23年至今国产GLP-1出海交易频现，我们认为国产GLP-1产品竞争力不输海外，其中GLP-1口服小分子、GLP-1/GIP、GLP-1/GIP/GCGR、GLP-1/GCGR/FGF21、ActRII等靶点不乏临床进展领先的优质资产，未来有望借助BD进军全球市场。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/25081848360318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU1979443071.USD","BK0183","LU1064130708.USD","LU1064131003.USD","BK0276","LU1934453819.USD","601688","GLP","BK0188","BK1147","LU1580142542.USD","BK0012","BK4144","LU2148510915.USD","LU1328615791.USD","06886","BK4590","BK1564","BK0028","LU1781817850.SGD"],"gpt_icon":0},{"id":"2514083586","title":"华泰证券：全球GLP-1产品空缺较大，并购潮有望持续","url":"https://stock-news.laohu8.com/highlight/detail?id=2514083586","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514083586?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 08:18","pubTimestamp":1740442696,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["06886","LU0672654240.SGD","LU0882574139.USD","LU1804176565.USD","IE00BJJMRZ35.SGD","LU0689472784.USD","LU2491050154.USD","LU1720051017.SGD","BK4599","LU2265009873.SGD","SG9999001176.SGD","LU0238689110.USD","LU2264538146.SGD","LU0154236417.USD","SG9999015978.USD","LU0198837287.USD","GLP","LU0943347566.SGD","LU1064131342.USD","BK4590","LU1623119135.USD","LU0203202063.USD","LU1814569148.SGD","LU0471298694.HKD","BK1147","LU2360106947.USD","LU2148510915.USD","NVO","SG9999014914.USD","LU0006306889.USD","LU1035775433.USD","SG9999018865.SGD","BK1564","LU1868837300.USD","LU0354030511.USD","LU2361045086.USD","LLY","BK4532","LU2063271972.USD","IE00B2B36J28.USD","SGXZ81514606.USD","HTSC.UK","LU0097036916.USD","SG9999015986.USD","601688","LU1988902786.USD","LU2361044949.HKD","LU0820561909.HKD","LU2361044865.SGD","SG9999014898.SGD"],"gpt_icon":0},{"id":"2514088406","title":"GLP-1研发风云录：MetaBio折戟沉沙，辉瑞缘何错失良机？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514088406","media":"药渡","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514088406?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 07:30","pubTimestamp":1740439838,"startTime":"0","endTime":"0","summary":"一个月后，MetaBio获得了GLP-1用于糖尿病疗法的全球独家许可。正式合作法律文件于1988年7月签署，MetaBio/辉瑞合作研发正式启动。2辉瑞退出GLP-1合作开发MetaBio/辉瑞联盟由一个联合研究委员会监督，辉瑞任命全球研发高级副总裁和中央研究院研发运营总监负责该项目，辉瑞参与者的资历表明了他们兴趣的强烈程度。辉瑞表示，将确定开发除注射以外的GLP-1给药途径，例如经鼻或经皮。当时MetaBio团队和创始人强烈反对辉瑞的观点。之后诺和诺德获得了哈贝纳的GLP-1专利权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225074833a25287d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225074833a25287d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BBT3K403.USD","LU0306807586.USD","BK4550","IE0002270589.USD","SG9999001176.USD","LU1894683264.USD","BK4599","LU1057294990.SGD","BK4568","SG9999013999.USD","GLP","BK4534","LU0170899867.USD","LU0122379950.USD","LU0225284248.USD","LU0306806265.USD","SG9999011175.SGD","PFE","BK4585","IE00B19Z3B42.SGD","LU0985481810.HKD","LU0058720904.USD","LU0321505439.SGD","IE00B19Z3581.USD","BK4007","LU0321505868.SGD","LU1066053197.SGD","BK4144","BK4592","SG9999003800.SGD","LU1883839398.USD","LU0289739699.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","LU0234572021.USD","BK4533","IE00BLSP4239.USD","LU0456855351.SGD","BK4588","LU1023059063.AUD","LU0868494617.USD","BK4590","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002232.USD","LU1066051498.USD","LU0225771236.USD","LU1894683348.USD","IE000M9KFDE8.USD","BK4581"],"gpt_icon":1},{"id":"2513717846","title":"【华东医药：HDM1005注射液临床试验申请获批】华东医药公告，2025年2月24日，全资子公司杭州中美华东制药有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，由中美华东申报的HDM1005注射液临床试验申请获得批准。HDM1005注射液用于阻塞性睡眠呼吸暂停（OSA）合并肥胖或超重成人患者的治疗，是多肽类人GLP-1受体和GIP受体的双靶点长效激动剂。该药物在中国的临床试验于2024年3月获得批准，适应症为2型糖尿病、超重或肥胖人群的体重管理。目前，HDM1005注射液正在积极推进II期临床试验相关工作。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513717846","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513717846?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 16:46","pubTimestamp":1740386764,"startTime":"0","endTime":"0","summary":"华东医药公告，2025年2月24日，全资子公司杭州中美华东制药有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，由中美华东申报的HDM1005注射液临床试验申请获得批准。HDM1005注射液用于阻塞性睡眠呼吸暂停（OSA）合并肥胖或超重成人患者的治疗，是多肽类人GLP-1受体和GIP受体的双靶点长效激动剂。该药物在中国的临床试验于2024年3月获得批准，适应症为2型糖尿病、超重或肥胖人群的体重管理。目前，HDM1005注射液正在积极推进II期临床试验相关工作。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24164648344287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0132","BK0196","BK0175","BK1574","BK4590","000963","BK0187","03347","GLP","LU1969619763.USD","BK0209","BK1141","01477","BK0183","BK1576","LU2328871848.SGD","BK4144","BK1191","BK0188","BK1583"],"gpt_icon":0},{"id":"2513798267","title":"华泰证券：国产GLP-1产品有望抢占全球市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2513798267","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513798267?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 10:02","pubTimestamp":1740362546,"startTime":"0","endTime":"0","summary":"2月24日，华泰证券发布医药健康行业深度研究报告称，GLP-1已展现较大的市场潜力，而目前海外MNC仅诺和诺德和礼来两巨头销售领先，但尚未形成完整产品矩阵，其他MNC产品仍处于临床阶段，竞争格局尚未定型，产品空缺较大。而2023年至今国产GLP-1出海交易频现，华泰证券认为国产GLP-1产品竞争力不输海外，其中GLP-1口服小分子、GLP-1/GIP、GLP-1/GIP/GCGR、GLP-1/GCGR/FGF21、ActRII等靶点不乏临床进展领先的优质资产，未来有望借助BD进军全球市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224100328962dd889&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224100328962dd889&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0002141913.USD","NVO","BK4144","LU0058720904.USD","IE00B4R5TH58.HKD","LU0868494617.USD","LU0109394709.USD","LU0289739699.SGD","BK4588","LU1983299246.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1057294990.SGD","LU0320765992.SGD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4585","LU1571399168.USD","BK4581","IE00BFTCPJ56.SGD","LU2242646821.SGD","BK4534","SG9999001440.SGD","AMGN","LU1061106388.HKD","BK4566","BK4599","LLY","LU0889565916.HKD","LU2242652126.USD","BK4139","BK4590","BK4533","LU0122379950.USD","GLP","IE0009355771.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2513224764","title":"中信建投：出海迎来新机会，持续看好创新药行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2513224764","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513224764?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 08:59","pubTimestamp":1740358773,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4080","BK1161","159992","BK4590","06978","BK4144","601066","BK1574","ADC","GLP","BK0276","BK4231"],"gpt_icon":0},{"id":"2513761727","title":"【中信建投：出海迎来新机会，持续看好创新药行业】中信建投研报表示，近年来，创新药企营业收入逐步增长，亏损实现缩窄，研发费用基本持平。在政策上，集采与医保谈判常态化，商保带来潜在增量，对创新药的支持力度有望进一步增加。在技术上，全球ADC药物2023年销售额达104亿美元，中国相关公司加速ADC布局与推进，逐渐迎来收获期；GLP-1减重赛道发展成熟，竞争从单一减重升级到多重获益，新靶点存在潜在出海机会；IO多抗赛道AK112率先实现突破，TCE技术从血液瘤走向实体瘤和自免。我国创新药全球竞争力持续增强，NewCo模式成为创新药出海新选择。国家政策鼓励创新药发展，新技术推动行业快速发展，出海迎来新机会，我们持续看好创新药行业。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513761727","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513761727?lang=zh_cn&edition=fundamental","pubTime":"2025-02-24 08:21","pubTimestamp":1740356473,"startTime":"0","endTime":"0","summary":"中信建投研报表示，近年来，创新药企营业收入逐步增长，亏损实现缩窄，研发费用基本持平。在政策上，集采与医保谈判常态化，商保带来潜在增量，对创新药的支持力度有望进一步增加。在技术上，全球ADC药物2023年销售额达104亿美元，中国相关公司加速ADC布局与推进，逐渐迎来收获期；GLP-1减重赛道发展成熟，竞争从单一减重升级到多重获益，新靶点存在潜在出海机会；IO多抗赛道AK112率先实现突破，TCE技术从血液瘤走向实体瘤和自免。我国创新药全球竞争力持续增强，NewCo模式成为创新药出海新选择。国家政策鼓励创新药发展，新技术推动行业快速发展，出海迎来新机会，我们持续看好创新药行业。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/24082148333573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GLP","159992","601066","06978","ADC"],"gpt_icon":0},{"id":"2512452187","title":"金十数据整理：每日港股市场要闻速递（2月20日 周四）","url":"https://stock-news.laohu8.com/highlight/detail?id=2512452187","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512452187?lang=zh_cn&edition=fundamental","pubTime":"2025-02-20 09:07","pubTimestamp":1740013643,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1561","00293","BK1128","BK1515","BK0183","HSCEI","BK1560","07226","06826","BK1191","BK4108","BK0077","BK1235","BK1574","HSTECH","01477","BK1123","BK1569","BK0196","09880","GLP","09696","01970","BK4590","BK1581","IMAX","YANG","BK1593","BK0197","BK1161","BK1183","01672","BK0028","BK1240","BK4144","03698","00432","BK1613","BK1129","02490","BK0233","002466","BK1103","SG9999014674.SGD","BK0155","BK0182"],"gpt_icon":0},{"id":"2512486421","title":"服用GLP-1降糖药后失明？诺和诺德回应：不能证实存在因果关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486421","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512486421?lang=zh_cn&edition=fundamental","pubTime":"2025-02-19 23:28","pubTimestamp":1739978895,"startTime":"0","endTime":"0","summary":"近日，《美国医学会杂志-眼科学》（JAMA）发布的一篇研究论文指出，有患者在使用诺和诺德的司美格鲁肽或者礼来的替尔泊肽等GLP-1类药物后出现了眼部的并发症，如非动脉炎性前部缺血性视神经病变（NAION）、视盘血管炎，以及黄斑旁中心中层视网膜病变（PAMM）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502193323925218.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502193323925218.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GLP","BK4144","LU0154236417.USD","LU1093756168.USD","LU1093756325.SGD","NVO","BK4585","IE00BZ1G4Q59.USD","BK4599","BK4532","BK4007","BK4588","IE00BKVL7J92.USD","BK4590"],"gpt_icon":1},{"id":"2512037661","title":"歌礼制药-B(01672)宣布小分子口服GLP-1R激动剂ASC30美国Ib期多剂量递增研究前两个队列取得积极期中结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2512037661","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512037661?lang=zh_cn&edition=fundamental","pubTime":"2025-02-19 19:47","pubTimestamp":1739965630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 公布，ASC30在美国开展的每日一次口服片用于治疗肥胖症患者的随机、双盲、安慰剂对照的Ib期多剂量递增研究前两个队列取得积极期中结果。该项Ib期MAD研究包括3个队列，每个队列中8名患者服用ASC30片，2名患者服用安慰剂。在整个28天治疗期内，队列1的ASC30平均每日剂量为9.25毫克。ASC30的每周剂量递增给药提高了胃肠道的耐受性。据悉，ASC30口服片MAD研究为一项随机、双盲、安慰剂对照的研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251821.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GLP","BK1515","BK4144","01477","BK1191","BK1574","BK4590","01672","BK1161"],"gpt_icon":0},{"id":"2512817483","title":"Websea启动全球合伙人招募计划，携手共建加密生态新未来","url":"https://stock-news.laohu8.com/highlight/detail?id=2512817483","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512817483?lang=zh_cn&edition=fundamental","pubTime":"2025-02-19 18:00","pubTimestamp":1739959200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/282343","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK4590","GLP","BK4144"],"gpt_icon":0},{"id":"2512017420","title":"Websea启动全球合伙人招募计划，携手共建加密生态新未来","url":"https://stock-news.laohu8.com/highlight/detail?id=2512017420","media":"世链财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512017420?lang=zh_cn&edition=fundamental","pubTime":"2025-02-19 18:00","pubTimestamp":1739959200,"startTime":"0","endTime":"0","summary":"2 月 19 日，游戏社交加密平台 Websea 近日宣布启动全球合伙人招募计划，计划在全球范围内招募 500 位加密爱好者、社群领袖以及社媒博主等意见领袖。成功加入的合伙人将享有丰厚的权益，包括但不限于：· 平台币质押收益分红： 合伙人可通过质押平台币获得稳定收益· 合约手续费返佣： 合伙人可享受","market":"hk","thumbnail":"https://m.shilian.com/assets/addons/cms/img/noimage/145.jpg","type":0,"news_type":0,"thumbnails":["https://m.shilian.com/assets/addons/cms/img/noimage/145.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.shilian.com//kuaixun/784357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"shilian_live","symbols":["GLP","BK4144","BK4590"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":147,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-28","symbol":"GLP","fiscalQuarterEnding":"2024/12","expectedEps":0.24,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"pre","actualEps":0.52},{"date":"2025-02-10","symbol":"GLP","amount":0.74,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-10","defaultRemindTime":1739197800000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-14","payableDate":"2025-02-10","currency":"USD","dateTimestamp":1739163600000,"payDate":"2025-02-14"},{"date":"2024-11-08","symbol":"GLP","amount":0.73,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-08","defaultRemindTime":1731076200000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-14","payableDate":"2024-11-08","currency":"USD","dateTimestamp":1731042000000,"payDate":"2024-11-14"},{"market":"US","date":"2024-11-08","symbol":"GLP","fiscalQuarterEnding":"2024/09","expectedEps":1.57,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":1.17},{"date":"2024-08-08","symbol":"GLP","amount":0.72,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-08-08","defaultRemindTime":1723123800000,"name":"全球合伙","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-14","payableDate":"2024-08-08","currency":"USD","dateTimestamp":1723089600000,"payDate":"2024-08-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLP\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-04","recordDate":"2015-05-06","paymentDate":"2015-05-15","value":0.68,"currency":"USD"},{"executeDate":"2015-08-03","recordDate":"2015-08-05","paymentDate":"2015-08-14","value":0.6925,"currency":"USD"},{"executeDate":"2015-11-02","recordDate":"2015-11-04","paymentDate":"2015-11-13","value":0.6975,"currency":"USD"},{"executeDate":"2016-02-08","recordDate":"2016-02-10","paymentDate":"2016-02-16","value":0.4625,"currency":"USD"},{"executeDate":"2016-05-04","recordDate":"2016-05-06","paymentDate":"2016-05-16","value":0.4625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":2,"updateTime":1741233600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GLP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GLP","date":"2025-04-21","current":18.509538,"percent":0.885273,"low":2.771386,"twenty":4.270877,"median":9.726256,"eighty":15.350956,"high":29.34912,"avg":10.428443,"sd":6.24379,"marketCap":1709337357},"quantilePoints":[{"date":"2020-04-24","current":10.885399,"twenty":6.299451,"median":7.87934,"eighty":11.115597,"marketCap":375415632},{"date":"2020-05-01","current":11.300646,"twenty":6.299659,"median":7.88907,"eighty":11.255307,"marketCap":389736665},{"date":"2020-05-08","current":11.690231,"twenty":6.299659,"median":7.896854,"eighty":11.255307,"marketCap":361461939},{"date":"2020-05-15","current":10.863092,"twenty":6.299659,"median":7.912422,"eighty":11.245121,"marketCap":335886802},{"date":"2020-05-22","current":11.182919,"twenty":6.299659,"median":7.932539,"eighty":11.262234,"marketCap":345775855},{"date":"2020-05-29","current":11.24909,"twenty":6.299659,"median":7.943558,"eighty":11.269162,"marketCap":347821866},{"date":"2020-06-05","current":12.451199,"twenty":6.307959,"median":7.955234,"eighty":11.298028,"marketCap":384991066},{"date":"2020-06-12","current":11.557889,"twenty":6.309309,"median":7.998046,"eighty":11.32112,"marketCap":357369917},{"date":"2020-06-19","current":11.072634,"twenty":6.3117,"median":8.066523,"eighty":11.332667,"marketCap":342365837},{"date":"2020-06-26","current":10.708693,"twenty":6.3117,"median":8.171888,"eighty":11.326893,"marketCap":331112776},{"date":"2020-07-02","current":10.752807,"twenty":6.317715,"median":8.211094,"eighty":11.322275,"marketCap":332476784},{"date":"2020-07-10","current":10.43298,"twenty":6.321861,"median":8.267451,"eighty":11.32112,"marketCap":322587731},{"date":"2020-07-17","current":10.13521,"twenty":6.32825,"median":8.287054,"eighty":11.316433,"marketCap":313380681},{"date":"2020-07-24","current":10.543265,"twenty":6.333279,"median":8.291955,"eighty":11.303569,"marketCap":325997749},{"date":"2020-07-31","current":11.800516,"twenty":6.334178,"median":8.348313,"eighty":11.303569,"marketCap":364871958},{"date":"2020-08-07","current":4.73435,"twenty":6.333279,"median":8.360564,"eighty":11.32112,"marketCap":438154667},{"date":"2020-08-14","current":5.006778,"twenty":6.3117,"median":8.298445,"eighty":11.316433,"marketCap":463367300},{"date":"2020-08-21","current":4.712262,"twenty":6.299659,"median":8.287054,"eighty":11.303569,"marketCap":436110400},{"date":"2020-08-28","current":4.701217,"twenty":6.299607,"median":8.274802,"eighty":11.298552,"marketCap":435088266},{"date":"2020-09-04","current":4.542915,"twenty":6.2824,"median":8.213544,"eighty":11.285346,"marketCap":420437682},{"date":"2020-09-11","current":4.749076,"twenty":6.27606,"median":8.174338,"eighty":11.274368,"marketCap":439517512},{"date":"2020-09-18","current":4.815342,"twenty":6.275736,"median":8.086126,"eighty":11.269162,"marketCap":445650315},{"date":"2020-09-25","current":4.73435,"twenty":6.258044,"median":8.00583,"eighty":11.265698,"marketCap":438154667},{"date":"2020-10-02","current":4.933149,"twenty":6.250305,"median":7.971673,"eighty":11.259925,"marketCap":456553075},{"date":"2020-10-09","current":5.360198,"twenty":6.244429,"median":7.94745,"eighty":11.2525,"marketCap":496075580},{"date":"2020-10-16","current":5.26448,"twenty":6.239772,"median":7.932539,"eighty":11.247278,"marketCap":487217087},{"date":"2020-10-23","current":5.271843,"twenty":6.23717,"median":7.912422,"eighty":11.243223,"marketCap":487898510},{"date":"2020-10-30","current":5.338109,"twenty":6.227089,"median":7.896854,"eighty":11.239367,"marketCap":494031312},{"date":"2020-11-06","current":5.459545,"twenty":6.22179,"median":7.88907,"eighty":11.21862,"marketCap":522855188},{"date":"2020-11-13","current":5.670214,"twenty":6.203808,"median":7.87934,"eighty":11.19873,"marketCap":543030764},{"date":"2020-11-20","current":5.877313,"twenty":6.196135,"median":7.85015,"eighty":11.194013,"marketCap":562864382},{"date":"2020-11-27","current":6.170107,"twenty":6.185826,"median":7.85015,"eighty":11.189536,"marketCap":590905013},{"date":"2020-12-04","current":6.109406,"twenty":6.168749,"median":7.838474,"eighty":11.169685,"marketCap":585091712},{"date":"2020-12-11","current":6.416483,"twenty":6.167844,"median":7.834582,"eighty":11.145422,"marketCap":614500179},{"date":"2020-12-18","current":6.230809,"twenty":6.167844,"median":7.828744,"eighty":11.130907,"marketCap":596718315},{"date":"2020-12-24","current":6.048705,"twenty":6.167844,"median":7.82096,"eighty":11.115597,"marketCap":579278410},{"date":"2020-12-31","current":5.934444,"twenty":6.167844,"median":7.817068,"eighty":11.101741,"marketCap":568335725},{"date":"2021-01-08","current":6.062987,"twenty":6.149862,"median":7.795662,"eighty":11.084422,"marketCap":580646246},{"date":"2021-01-15","current":6.216526,"twenty":6.149862,"median":7.785585,"eighty":11.084422,"marketCap":595350479},{"date":"2021-01-22","current":6.705707,"twenty":6.149862,"median":7.780094,"eighty":11.074992,"marketCap":642198851},{"date":"2021-01-29","current":7.180605,"twenty":6.149862,"median":7.776202,"eighty":11.068208,"marketCap":687679388},{"date":"2021-02-05","current":7.284155,"twenty":6.149862,"median":7.768418,"eighty":11.06411,"marketCap":697596196},{"date":"2021-02-12","current":6.934229,"twenty":6.163202,"median":7.760634,"eighty":11.053134,"marketCap":664084222},{"date":"2021-02-19","current":7.112763,"twenty":6.167321,"median":7.75285,"eighty":11.04396,"marketCap":681182168},{"date":"2021-02-26","current":7.202029,"twenty":6.167844,"median":7.741174,"eighty":11.038761,"marketCap":689731141},{"date":"2021-03-05","current":6.896217,"twenty":6.167844,"median":7.718575,"eighty":11.032407,"marketCap":695214499},{"date":"2021-03-12","current":7.842623,"twenty":6.167844,"median":7.698362,"eighty":11.017031,"marketCap":790622686},{"date":"2021-03-19","current":7.720506,"twenty":6.167844,"median":7.718575,"eighty":11.007626,"marketCap":778311953},{"date":"2021-03-26","current":7.411822,"twenty":6.167844,"median":7.69367,"eighty":11.00501,"marketCap":747193153},{"date":"2021-04-01","current":7.320234,"twenty":6.167844,"median":7.686686,"eighty":10.988222,"marketCap":737960103},{"date":"2021-04-09","current":7.3779,"twenty":6.167844,"median":7.67501,"eighty":10.954813,"marketCap":743773505},{"date":"2021-04-16","current":7.510194,"twenty":6.168749,"median":7.659442,"eighty":10.940212,"marketCap":757110133},{"date":"2021-04-23","current":7.364332,"twenty":6.170107,"median":7.594997,"eighty":10.930856,"marketCap":742405645},{"date":"2021-04-30","current":8.185229,"twenty":6.171613,"median":7.641929,"eighty":10.912383,"marketCap":825161134},{"date":"2021-05-07","current":9.181725,"twenty":6.178654,"median":7.67501,"eighty":10.905455,"marketCap":849502414},{"date":"2021-05-14","current":8.749253,"twenty":6.185826,"median":7.686686,"eighty":10.905455,"marketCap":809489619},{"date":"2021-05-21","current":9.203903,"twenty":6.185826,"median":7.690578,"eighty":10.897433,"marketCap":851554353},{"date":"2021-05-28","current":9.407203,"twenty":6.185826,"median":7.712361,"eighty":10.877257,"marketCap":870363786},{"date":"2021-06-04","current":9.706607,"twenty":6.189262,"median":7.720506,"eighty":10.864653,"marketCap":898064952},{"date":"2021-06-11","current":10.061456,"twenty":6.203126,"median":7.741174,"eighty":10.858681,"marketCap":930895963},{"date":"2021-06-18","current":9.603109,"twenty":6.203644,"median":7.748958,"eighty":10.836624,"marketCap":888489240},{"date":"2021-06-25","current":9.680732,"twenty":6.203808,"median":7.760634,"eighty":10.817799,"marketCap":895671024},{"date":"2021-07-02","current":9.658554,"twenty":6.203808,"median":7.768418,"eighty":10.809851,"marketCap":893619086},{"date":"2021-07-09","current":9.31849,"twenty":6.203808,"median":7.778148,"eighty":10.796921,"marketCap":862156033},{"date":"2021-07-16","current":8.963641,"twenty":6.213362,"median":7.780094,"eighty":10.785892,"marketCap":829325022},{"date":"2021-07-23","current":9.495915,"twenty":6.213362,"median":7.785616,"eighty":10.763835,"marketCap":878571539},{"date":"2021-07-30","current":9.909906,"twenty":6.216526,"median":7.795662,"eighty":10.752807,"marketCap":916874385},{"date":"2021-08-06","current":29.34912,"twenty":6.22179,"median":7.817068,"eighty":10.752807,"marketCap":823536295},{"date":"2021-08-13","current":26.023372,"twenty":6.22179,"median":7.822906,"eighty":10.813084,"marketCap":730215805},{"date":"2021-08-20","current":24.554702,"twenty":6.22179,"median":7.83069,"eighty":10.865043,"marketCap":689004931},{"date":"2021-08-27","current":24.530426,"twenty":6.22179,"median":7.834582,"eighty":10.905455,"marketCap":688323760},{"date":"2021-09-03","current":25.100901,"twenty":6.22179,"median":7.842494,"eighty":10.964493,"marketCap":704331289},{"date":"2021-09-10","current":24.275533,"twenty":6.228856,"median":7.848204,"eighty":11.013201,"marketCap":681171460},{"date":"2021-09-17","current":25.198003,"twenty":6.230622,"median":7.85015,"eighty":11.053134,"marketCap":707055975},{"date":"2021-09-24","current":24.894559,"twenty":6.230772,"median":7.876969,"eighty":11.084422,"marketCap":698541332},{"date":"2021-10-01","current":26.047647,"twenty":6.233421,"median":7.883329,"eighty":11.141011,"marketCap":730896976},{"date":"2021-10-08","current":26.897291,"twenty":6.234318,"median":7.892962,"eighty":11.19642,"marketCap":754737977},{"date":"2021-10-15","current":26.836602,"twenty":6.236185,"median":7.896854,"eighty":11.246674,"marketCap":753035049},{"date":"2021-10-22","current":28.632991,"twenty":6.237348,"median":7.914368,"eighty":11.269162,"marketCap":803441737},{"date":"2021-10-29","current":28.329547,"twenty":6.237865,"median":7.935774,"eighty":11.303569,"marketCap":794927093},{"date":"2021-11-05","current":18.151279,"twenty":6.239408,"median":7.94745,"eighty":11.328048,"marketCap":776838422},{"date":"2021-11-12","current":18.191189,"twenty":6.239772,"median":7.988112,"eighty":11.346522,"marketCap":778546510},{"date":"2021-11-19","current":18.773882,"twenty":6.239772,"median":8.014118,"eighty":11.360961,"marketCap":803484595},{"date":"2021-11-26","current":18.694061,"twenty":6.239772,"median":8.035981,"eighty":11.378852,"marketCap":800068419},{"date":"2021-12-03","current":18.103386,"twenty":6.239772,"median":8.105729,"eighty":11.403489,"marketCap":774788716},{"date":"2021-12-10","current":18.430652,"twenty":6.240495,"median":8.179783,"eighty":11.427136,"marketCap":788795038},{"date":"2021-12-17","current":18.550383,"twenty":6.243048,"median":8.213544,"eighty":11.470285,"marketCap":793919302},{"date":"2021-12-23","current":17.991637,"twenty":6.244429,"median":8.252749,"eighty":11.474686,"marketCap":770006070},{"date":"2021-12-31","current":18.749936,"twenty":6.244429,"median":8.284603,"eighty":11.575574,"marketCap":802459742},{"date":"2022-01-07","current":20.051017,"twenty":6.24581,"median":8.291955,"eighty":11.616705,"marketCap":858143411},{"date":"2022-01-14","current":21.152545,"twenty":6.248234,"median":8.320498,"eighty":11.690231,"marketCap":905286640},{"date":"2022-01-21","current":20.146802,"twenty":6.249277,"median":8.363015,"eighty":11.729858,"marketCap":862242822},{"date":"2022-01-28","current":21.392008,"twenty":6.251718,"median":8.365465,"eighty":11.776801,"marketCap":915535168},{"date":"2022-02-04","current":21.85497,"twenty":6.254157,"median":8.433466,"eighty":11.837284,"marketCap":935348988},{"date":"2022-02-11","current":21.559632,"twenty":6.257754,"median":8.47328,"eighty":11.938846,"marketCap":922709137},{"date":"2022-02-18","current":20.945011,"twenty":6.257851,"median":8.48054,"eighty":12.432666,"marketCap":896404582},{"date":"2022-02-25","current":20.529942,"twenty":6.258237,"median":8.487891,"eighty":12.775373,"marketCap":878640467},{"date":"2022-03-04","current":15.348683,"twenty":6.268592,"median":8.571294,"eighty":13.121553,"marketCap":878174885},{"date":"2022-03-11","current":15.504022,"twenty":6.275496,"median":8.601399,"eighty":13.154839,"marketCap":887062603},{"date":"2022-03-18","current":15.940166,"twenty":6.275736,"median":8.649704,"eighty":13.201441,"marketCap":912016580},{"date":"2022-03-25","current":16.890123,"twenty":6.275736,"median":8.669307,"eighty":13.248042,"marketCap":966368393},{"date":"2022-04-01","current":16.214996,"twenty":6.275736,"median":8.68891,"eighty":13.261356,"marketCap":927741004},{"date":"2022-04-08","current":16.752708,"twenty":6.275736,"median":8.726599,"eighty":13.281328,"marketCap":958506181},{"date":"2022-04-14","current":16.573471,"twenty":6.275736,"median":8.736337,"eighty":13.3013,"marketCap":948251122},{"date":"2022-04-22","current":16.011861,"twenty":6.276168,"median":8.777122,"eighty":13.329261,"marketCap":916118604},{"date":"2022-04-29","current":15.743005,"twenty":6.281175,"median":8.797306,"eighty":13.342575,"marketCap":900736015},{"date":"2022-05-06","current":9.804164,"twenty":6.2824,"median":8.848712,"eighty":13.349233,"marketCap":897659497},{"date":"2022-05-13","current":9.69216,"twenty":6.2824,"median":8.9103,"eighty":13.347901,"marketCap":887404438},{"date":"2022-05-20","current":10.270852,"twenty":6.291454,"median":8.930374,"eighty":13.347901,"marketCap":940388910},{"date":"2022-05-27","current":11.163158,"twenty":6.293718,"median":8.972794,"eighty":13.342575,"marketCap":1022087547},{"date":"2022-06-03","current":10.868211,"twenty":6.294536,"median":8.995202,"eighty":13.341244,"marketCap":995082558},{"date":"2022-06-10","current":10.244717,"twenty":6.297672,"median":9.026396,"eighty":13.341244,"marketCap":937996063},{"date":"2022-06-17","current":7.754474,"twenty":6.299555,"median":9.016925,"eighty":13.33725,"marketCap":709991918},{"date":"2022-06-24","current":8.613179,"twenty":6.299659,"median":8.99034,"eighty":13.331924,"marketCap":788614037},{"date":"2022-07-01","current":8.814788,"twenty":6.299659,"median":8.977241,"eighty":13.322603,"marketCap":807073143},{"date":"2022-07-08","current":8.900658,"twenty":6.299659,"median":8.963641,"eighty":13.313284,"marketCap":814935355},{"date":"2022-07-15","current":8.867057,"twenty":6.299659,"median":8.92485,"eighty":13.306626,"marketCap":811858837},{"date":"2022-07-22","current":9.561487,"twenty":6.300172,"median":8.963641,"eighty":13.3013,"marketCap":875440203},{"date":"2022-07-29","current":10.371656,"twenty":6.303369,"median":8.980096,"eighty":13.299969,"marketCap":949618463},{"date":"2022-08-05","current":3.850073,"twenty":6.303369,"median":8.997729,"eighty":13.29198,"marketCap":927520968},{"date":"2022-08-12","current":4.016293,"twenty":6.299659,"median":8.972794,"eighty":13.281328,"marketCap":967565231},{"date":"2022-08-19","current":3.999245,"twenty":6.293991,"median":8.937993,"eighty":13.278687,"marketCap":963458127},{"date":"2022-08-26","current":3.899797,"twenty":6.2824,"median":8.919306,"eighty":13.268103,"marketCap":939500021},{"date":"2022-09-02","current":4.077383,"twenty":6.275736,"median":8.9103,"eighty":13.268014,"marketCap":982282354},{"date":"2022-09-09","current":4.169728,"twenty":6.275496,"median":8.900658,"eighty":13.268014,"marketCap":1004529167},{"date":"2022-09-16","current":4.014873,"twenty":6.257754,"median":8.857885,"eighty":13.261356,"marketCap":967222973},{"date":"2022-09-23","current":3.607134,"twenty":6.247881,"median":8.814788,"eighty":13.254699,"marketCap":868994737},{"date":"2022-09-30","current":3.51621,"twenty":6.240977,"median":8.791187,"eighty":13.254699,"marketCap":847090183},{"date":"2022-10-07","current":3.916845,"twenty":6.239772,"median":8.777122,"eighty":13.248042,"marketCap":943607125},{"date":"2022-10-14","current":3.740679,"twenty":6.236636,"median":8.755886,"eighty":13.248042,"marketCap":901167051},{"date":"2022-10-21","current":4.087328,"twenty":6.230622,"median":8.734756,"eighty":13.241384,"marketCap":984678164},{"date":"2022-10-28","current":4.250707,"twenty":6.22179,"median":8.716798,"eighty":13.234727,"marketCap":1024037910},{"date":"2022-11-04","current":3.449288,"twenty":6.213362,"median":8.68891,"eighty":13.208098,"marketCap":1095762902},{"date":"2022-11-11","current":3.301892,"twenty":6.203808,"median":8.669307,"eighty":13.201441,"marketCap":1048938349},{"date":"2022-11-18","current":3.311575,"twenty":6.185826,"median":8.649704,"eighty":13.194783,"marketCap":1052014414},{"date":"2022-11-25","current":3.399797,"twenty":6.17312,"median":8.639313,"eighty":13.17348,"marketCap":1080040789},{"date":"2022-12-02","current":3.385811,"twenty":6.167844,"median":8.62969,"eighty":13.162828,"marketCap":1075597583},{"date":"2022-12-09","current":3.518145,"twenty":6.167844,"median":8.601399,"eighty":13.156171,"marketCap":1117637146},{"date":"2022-12-16","current":3.574091,"twenty":6.149862,"median":8.577106,"eighty":13.154839,"marketCap":1135409969},{"date":"2022-12-23","current":3.865656,"twenty":6.146266,"median":8.549709,"eighty":13.144188,"marketCap":1228033720},{"date":"2022-12-30","current":3.740853,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1188386653},{"date":"2023-01-06","current":3.441757,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1093370406},{"date":"2023-01-13","current":3.612823,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1147714231},{"date":"2023-01-20","current":3.620354,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1150106726},{"date":"2023-01-27","current":3.857048,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1225299440},{"date":"2023-02-03","current":4.130323,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1312112845},{"date":"2023-02-10","current":3.93774,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1250933319},{"date":"2023-02-17","current":3.875339,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1231109786},{"date":"2023-02-24","current":3.718259,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1181209167},{"date":"2023-03-03","current":3.363192,"twenty":6.130032,"median":8.492883,"eighty":13.133536,"marketCap":1194165378},{"date":"2023-03-10","current":3.211151,"twenty":6.113691,"median":8.482899,"eighty":13.133536,"marketCap":1140180220},{"date":"2023-03-17","current":2.830086,"twenty":6.097582,"median":8.463126,"eighty":13.133536,"marketCap":1004875645},{"date":"2023-03-24","current":2.875313,"twenty":6.070129,"median":8.365465,"eighty":13.133536,"marketCap":1020934521},{"date":"2023-03-31","current":2.985014,"twenty":6.034422,"median":8.291955,"eighty":13.130873,"marketCap":1059885838},{"date":"2023-04-06","current":2.892634,"twenty":6.016569,"median":8.274802,"eighty":13.130873,"marketCap":1027084729},{"date":"2023-04-14","current":2.896483,"twenty":5.960153,"median":8.185229,"eighty":13.133536,"marketCap":1028451442},{"date":"2023-04-20","current":2.925352,"twenty":5.879004,"median":8.105729,"eighty":13.133536,"marketCap":1038701788},{"date":"2023-04-28","current":2.932088,"twenty":5.726233,"median":7.998046,"eighty":13.136199,"marketCap":1041093536},{"date":"2023-05-05","current":2.771386,"twenty":5.536171,"median":7.943558,"eighty":13.136199,"marketCap":984033273},{"date":"2023-05-12","current":2.975648,"twenty":5.442294,"median":7.932539,"eighty":13.136199,"marketCap":1050433502},{"date":"2023-05-19","current":3.089052,"twenty":5.341054,"median":7.932539,"eighty":13.136199,"marketCap":1090466310},{"date":"2023-05-26","current":2.874844,"twenty":5.253436,"median":7.932539,"eighty":13.136199,"marketCap":1014848784},{"date":"2023-06-02","current":2.846736,"twenty":5.130475,"median":7.932539,"eighty":13.136199,"marketCap":1004926122},{"date":"2023-06-09","current":3.07839,"twenty":5.004569,"median":7.932539,"eighty":13.136199,"marketCap":1086702542},{"date":"2023-06-16","current":3.058036,"twenty":4.918423,"median":7.932539,"eighty":13.136199,"marketCap":1079517166},{"date":"2023-06-23","current":2.916523,"twenty":4.864674,"median":7.935774,"eighty":13.138862,"marketCap":1029561696},{"date":"2023-06-30","current":2.952386,"twenty":4.815342,"median":7.93772,"eighty":13.141525,"marketCap":1042221644},{"date":"2023-07-07","current":2.944631,"twenty":4.771165,"median":7.93772,"eighty":13.141525,"marketCap":1039484358},{"date":"2023-07-14","current":3.066759,"twenty":4.749076,"median":7.93772,"eighty":13.141525,"marketCap":1082596613},{"date":"2023-07-21","current":3.116192,"twenty":4.697536,"median":7.93772,"eighty":13.141525,"marketCap":1100046811},{"date":"2023-07-28","current":3.215057,"twenty":4.671766,"median":7.93772,"eighty":13.141525,"marketCap":1134947207},{"date":"2023-08-04","current":3.279998,"twenty":4.616544,"median":7.93772,"eighty":13.141525,"marketCap":1157871978},{"date":"2023-08-11","current":4.645552,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075069076},{"date":"2023-08-18","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-08-25","current":4.663295,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1079175005},{"date":"2023-09-01","current":4.624853,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1070278826},{"date":"2023-09-08","current":4.647031,"twenty":4.574583,"median":7.93772,"eighty":13.141525,"marketCap":1075411237},{"date":"2023-09-15","current":4.775663,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1105179222},{"date":"2023-09-22","current":4.867332,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1126393189},{"date":"2023-09-29","current":5.173389,"twenty":4.570147,"median":7.93772,"eighty":13.141525,"marketCap":1197220464},{"date":"2023-10-06","current":4.475521,"twenty":4.542915,"median":7.93772,"eighty":13.141525,"marketCap":1035720590},{"date":"2023-10-13","current":4.511006,"twenty":4.484012,"median":7.93772,"eighty":13.141525,"marketCap":1043932448},{"date":"2023-10-20","current":4.482914,"twenty":4.482914,"median":7.93772,"eighty":13.141525,"marketCap":1037431394},{"date":"2023-10-27","current":4.534662,"twenty":4.467537,"median":7.94745,"eighty":13.149513,"marketCap":1049407020},{"date":"2023-11-03","current":4.904296,"twenty":4.458666,"median":7.94745,"eighty":13.149513,"marketCap":1134947207},{"date":"2023-11-10","current":7.439549,"twenty":4.458666,"median":7.935774,"eighty":13.149513,"marketCap":1088071185},{"date":"2023-11-17","current":7.820894,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1143844827},{"date":"2023-11-24","current":7.993518,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1169092039},{"date":"2023-12-01","current":8.460278,"twenty":4.458666,"median":7.896854,"eighty":13.149513,"marketCap":1237357955},{"date":"2023-12-08","current":8.743603,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1278795691},{"date":"2023-12-15","current":8.690189,"twenty":4.459848,"median":7.902692,"eighty":13.146851,"marketCap":1270983658},{"date":"2023-12-22","current":9.616802,"twenty":4.459848,"median":7.934448,"eighty":13.146851,"marketCap":1406505433},{"date":"2023-12-29","current":9.686473,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1416695040},{"date":"2024-01-05","current":9.75382,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1426544994},{"date":"2024-01-12","current":9.809556,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1434696679},{"date":"2024-01-19","current":10.16023,"twenty":4.448612,"median":7.939666,"eighty":13.154839,"marketCap":1485984368},{"date":"2024-01-26","current":10.740814,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1570897761},{"date":"2024-02-02","current":10.601474,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1550518547},{"date":"2024-02-09","current":10.963759,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1603504503},{"date":"2024-02-16","current":11.124,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1626940600},{"date":"2024-02-23","current":10.647921,"twenty":4.452456,"median":7.93987,"eighty":13.154839,"marketCap":1557311618},{"date":"2024-03-01","current":11.10678,"twenty":4.4563,"median":7.940074,"eighty":13.154839,"marketCap":1583804596},{"date":"2024-03-08","current":11.32675,"twenty":4.4563,"median":7.94745,"eighty":13.154839,"marketCap":1615171958},{"date":"2024-03-15","current":10.799262,"twenty":4.4563,"median":7.990262,"eighty":13.154839,"marketCap":1539953125},{"date":"2024-03-22","current":11.659401,"twenty":4.4563,"median":8.049544,"eighty":13.154839,"marketCap":1662607257},{"date":"2024-03-28","current":10.571159,"twenty":4.4563,"median":8.239503,"eighty":13.154839,"marketCap":1507426062},{"date":"2024-04-05","current":10.811142,"twenty":4.452456,"median":8.461702,"eighty":13.154839,"marketCap":1541647243},{"date":"2024-04-12","current":11.186562,"twenty":4.452456,"median":8.566313,"eighty":13.154839,"marketCap":1595181367},{"date":"2024-04-19","current":10.81827,"twenty":4.452456,"median":8.624771,"eighty":13.154839,"marketCap":1542663714},{"date":"2024-04-26","current":11.245964,"twenty":4.4563,"median":8.639313,"eighty":13.154839,"marketCap":1603651956},{"date":"2024-05-03","current":11.324374,"twenty":4.4563,"median":8.690189,"eighty":13.154839,"marketCap":1614833134},{"date":"2024-05-10","current":14.682959,"twenty":4.4563,"median":8.734756,"eighty":13.168154,"marketCap":1565364893},{"date":"2024-05-17","current":13.78037,"twenty":4.4563,"median":8.734756,"eighty":13.224197,"marketCap":1469138999},{"date":"2024-05-24","current":14.166489,"twenty":4.4563,"median":8.734756,"eighty":13.241384,"marketCap":1510303519},{"date":"2024-05-31","current":14.905887,"twenty":4.4563,"median":8.734756,"eighty":13.248042,"marketCap":1589131510},{"date":"2024-06-07","current":15.724962,"twenty":4.4563,"median":8.734756,"eighty":13.254699,"marketCap":1676453895},{"date":"2024-06-14","current":15.619789,"twenty":4.452456,"median":8.72747,"eighty":13.254699,"marketCap":1665241293},{"date":"2024-06-21","current":14.485195,"twenty":4.448612,"median":8.720183,"eighty":13.254699,"marketCap":1544281101},{"date":"2024-06-28","current":14.60949,"twenty":4.437079,"median":8.698559,"eighty":13.248042,"marketCap":1557532358},{"date":"2024-07-05","current":14.552123,"twenty":4.437079,"median":8.698559,"eighty":13.254699,"marketCap":1551416394},{"date":"2024-07-12","current":13.854157,"twenty":4.437079,"median":8.698559,"eighty":13.254699,"marketCap":1477005489},{"date":"2024-07-15","current":13.586443,"twenty":4.437079,"median":8.698559,"eighty":13.254699,"marketCap":1448464320},{"date":"2024-08-02","current":13.149816,"twenty":4.293661,"median":8.639313,"eighty":12.179123,"marketCap":1401915033},{"date":"2024-08-09","current":12.65362,"twenty":4.293661,"median":8.639313,"eighty":12.333841,"marketCap":1357404400},{"date":"2024-08-16","current":12.71449,"twenty":4.293661,"median":8.639313,"eighty":12.422884,"marketCap":1363934183},{"date":"2024-08-23","current":13.275377,"twenty":4.293661,"median":8.639313,"eighty":12.626454,"marketCap":1424102779},{"date":"2024-08-30","current":14.261656,"twenty":4.293661,"median":8.639313,"eighty":13.112996,"marketCap":1529904861},{"date":"2024-09-06","current":13.281679,"twenty":4.293661,"median":8.639313,"eighty":13.211726,"marketCap":1424778831},{"date":"2024-09-13","current":13.861472,"twenty":4.293661,"median":8.639313,"eighty":13.294349,"marketCap":1486975582},{"date":"2024-09-20","current":13.839415,"twenty":4.293661,"median":8.639313,"eighty":13.376841,"marketCap":1484609401},{"date":"2024-09-27","current":14.00327,"twenty":4.293661,"median":8.639313,"eighty":13.543138,"marketCap":1502186744},{"date":"2024-10-04","current":14.854053,"twenty":4.293661,"median":8.639313,"eighty":13.653503,"marketCap":1593453715},{"date":"2024-10-11","current":14.854053,"twenty":4.293661,"median":8.639313,"eighty":13.84826,"marketCap":1593453715},{"date":"2024-10-18","current":14.737464,"twenty":4.293661,"median":8.639313,"eighty":13.994199,"marketCap":1580946760},{"date":"2024-10-25","current":15.008455,"twenty":4.293661,"median":8.639313,"eighty":14.123548,"marketCap":1610016980},{"date":"2024-10-31","current":14.655537,"twenty":4.293661,"median":8.639313,"eighty":14.202306,"marketCap":1572158088},{"date":"2024-11-08","current":15.118742,"twenty":4.28479,"median":8.64118,"eighty":14.37096,"marketCap":1621847884},{"date":"2024-11-15","current":13.409306,"twenty":4.28479,"median":8.692753,"eighty":14.37096,"marketCap":1673883715},{"date":"2024-11-22","current":14.009118,"twenty":4.28479,"median":8.746428,"eighty":14.37096,"marketCap":1748758223},{"date":"2024-11-29","current":15.251971,"twenty":4.28479,"median":8.78252,"eighty":14.384136,"marketCap":1903903601},{"date":"2024-12-06","current":15.416785,"twenty":4.28479,"median":8.81344,"eighty":14.484602,"marketCap":1924477227},{"date":"2024-12-13","current":14.881817,"twenty":4.28479,"median":8.908125,"eighty":14.552123,"marketCap":1857697260},{"date":"2024-12-20","current":12.709526,"twenty":4.28479,"median":8.950817,"eighty":14.552123,"marketCap":1586530122},{"date":"2024-12-27","current":12.995923,"twenty":4.28479,"median":9.012663,"eighty":14.552123,"marketCap":1622281013},{"date":"2025-01-03","current":12.674402,"twenty":4.28479,"median":9.065008,"eighty":14.552123,"marketCap":1582145578},{"date":"2025-01-10","current":12.901358,"twenty":4.275919,"median":9.188137,"eighty":14.552123,"marketCap":1610476474},{"date":"2025-01-17","current":14.179335,"twenty":4.275919,"median":9.277741,"eighty":14.552123,"marketCap":1770006394},{"date":"2025-01-24","current":13.960485,"twenty":4.275919,"median":9.31881,"eighty":14.552123,"marketCap":1742687317},{"date":"2025-01-31","current":15.316816,"twenty":4.275919,"median":9.382279,"eighty":14.568402,"marketCap":1911998142},{"date":"2025-02-07","current":15.738305,"twenty":4.275919,"median":9.466344,"eighty":14.652386,"marketCap":1964612662},{"date":"2025-02-14","current":15.435698,"twenty":4.275919,"median":9.483084,"eighty":14.687048,"marketCap":1926838135},{"date":"2025-02-21","current":16.178708,"twenty":4.275919,"median":9.514397,"eighty":14.715407,"marketCap":2019588089},{"date":"2025-02-28","current":15.284394,"twenty":4.275919,"median":9.568033,"eighty":14.816241,"marketCap":1907950871},{"date":"2025-03-07","current":19.286086,"twenty":4.270877,"median":9.582779,"eighty":14.884457,"marketCap":1781050742},{"date":"2025-03-14","current":19.942323,"twenty":4.270877,"median":9.582779,"eighty":14.985042,"marketCap":1841653603},{"date":"2025-03-21","current":19.862116,"twenty":4.270877,"median":9.595365,"eighty":15.085182,"marketCap":1834246586},{"date":"2025-03-28","current":19.719932,"twenty":4.270877,"median":9.649313,"eighty":15.125044,"marketCap":1821115967},{"date":"2025-04-04","current":20.186589,"twenty":4.270877,"median":9.689317,"eighty":15.233006,"marketCap":1864211334},{"date":"2025-04-11","current":16.708531,"twenty":4.275919,"median":9.707094,"eighty":15.273586,"marketCap":1543016172},{"date":"2025-04-17","current":18.524121,"twenty":4.275919,"median":9.710303,"eighty":15.333027,"marketCap":1710684087},{"date":"2025-04-21","current":18.509538,"twenty":4.270877,"median":9.726256,"eighty":15.350956,"marketCap":1709337357}],"updateTime":1745320798518}}}